Larry J Siever

Author PubWeight™ 113.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007 2.91
2 The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry 2002 2.75
3 Characterizing affective instability in borderline personality disorder. Am J Psychiatry 2002 2.44
4 Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 2004 2.06
5 Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2011 1.93
6 The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull 2006 1.88
7 The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry 2002 1.81
8 Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry 2004 1.71
9 Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 2007 1.54
10 Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr 2003 1.38
11 Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res 2007 1.36
12 Neural correlates of using distancing to regulate emotional responses to social situations. Neuropsychologia 2010 1.33
13 Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res 2009 1.32
14 Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2013 1.30
15 Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale. Personal Disord 2011 1.30
16 Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res 2008 1.29
17 The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry 2009 1.28
18 Personality disorder types proposed for DSM-5. J Pers Disord 2011 1.27
19 Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry 2002 1.27
20 Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res 2006 1.25
21 Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry 2005 1.23
22 Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005 1.22
23 Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry 2002 1.22
24 Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry 2009 1.21
25 Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry 2008 1.19
26 Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res 2009 1.18
27 The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry 2003 1.17
28 Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry 2009 1.17
29 Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry 2005 1.17
30 Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry 2011 1.12
31 Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol 2004 1.12
32 Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res 2007 1.11
33 Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder. Biol Psychiatry 2007 1.11
34 Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res 2008 1.10
35 Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) 2004 1.07
36 Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol 2008 1.07
37 Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res 2008 1.07
38 Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biol Psychiatry 2012 1.06
39 Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res 2007 1.05
40 Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res 2004 1.05
41 Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry 2003 1.04
42 Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res 2002 1.04
43 Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry 2003 1.03
44 A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry 2012 1.02
45 The role of childhood trauma in differences in affective instability in those with personality disorders. CNS Spectr 2003 1.00
46 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res 2004 1.00
47 Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res 2010 0.99
48 Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res 2011 0.97
49 Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology 2010 0.96
50 RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 2003 0.96
51 The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry 2006 0.95
52 Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage 2008 0.95
53 Recent advances in the biological study of personality disorders. Psychiatr Clin North Am 2008 0.93
54 Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res 2009 0.93
55 Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical application. Personal Disord 2011 0.92
56 Neurobiologic function and temperament in subjects with personality disorders. CNS Spectr 2003 0.92
57 Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophr Bull 2011 0.91
58 Dispositional impulsivity in normal and abnormal samples. J Psychiatr Res 2006 0.91
59 Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology 2010 0.89
60 Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 2010 0.89
61 Empathy and alexithymia in borderline personality disorder: clinical and laboratory measures. J Pers Disord 2012 0.88
62 Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res 2007 0.88
63 Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry 2013 0.88
64 Low prolactin response to fenfluramine in impulsive aggression. J Psychiatr Res 2004 0.88
65 Childhood trauma and basal cortisol in people with personality disorders. Compr Psychiatry 2008 0.87
66 Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family. Psychiatr Genet 2005 0.86
67 Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia. Neuropsychopharmacology 2012 0.85
68 The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572. Am J Med Genet B Neuropsychiatr Genet 2014 0.85
69 Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res 2010 0.84
70 Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res 2012 0.84
71 Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Psychiatr Genet 2006 0.84
72 Serotonin 2c receptor RNA editing in major depression and suicide. World J Biol Psychiatry 2012 0.84
73 The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients. Am J Psychiatry 2014 0.84
74 Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112. Psychopharmacology (Berl) 2014 0.84
75 Schizoid personality disorder. J Pers Disord 2012 0.83
76 The neurobiology of empathy in borderline personality disorder. Curr Psychiatry Rep 2013 0.83
77 Cingulate and temporal lobe fractional anisotropy in schizotypal personality disorder. Neuroimage 2011 0.82
78 Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis. Psychol Med 2005 0.82
79 Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences. Brain Res 2011 0.82
80 CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals. Psychiatry Res 2012 0.82
81 Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy. Schizophr Res 2012 0.81
82 Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder. Behav Brain Res 2010 0.81
83 Irritable assault and variation in the COMT gene. Psychiatr Genet 2007 0.81
84 Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr Res 2004 0.81
85 Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity. Neuropsychology 2006 0.81
86 Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study. J Clin Exp Neuropsychol 2003 0.80
87 Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences. J Psychiatr Res 2012 0.80
88 Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophr Res 2013 0.79
89 Schizotypal personality disorder: a current review. Curr Psychiatry Rep 2014 0.79
90 Psychometric properties of a short form of the Affective Lability Scale (ALS-18). Pers Individ Dif 2010 0.79
91 Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr Res 2015 0.79
92 Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions. Neuropsychiatr Dis Treat 2007 0.79
93 Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum. Arch Clin Neuropsychol 2006 0.78
94 Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent. Neuromolecular Med 2012 0.78
95 Deficient visual sensitivity in schizotypal personality disorder. Schizophr Res 2010 0.78
96 Empathic accuracy and cognition in schizotypal personality disorder. Psychiatry Res 2013 0.78
97 Eye tracking performance and the boundaries of the schizophrenia spectrum. Psychiatry Res 2010 0.77
98 Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study. J Child Adolesc Psychopharmacol 2003 0.77
99 Biochemical endophenotypes in personality disorders. Methods Mol Med 2003 0.77
100 Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder. Schizophr Res 2012 0.77
101 Hypermentalization in adolescents with borderline personality traits: extending the conceptual framework to younger ages. J Am Acad Child Adolesc Psychiatry 2011 0.77
102 Conflict of interest-- an issue for every psychiatrist. Am J Psychiatry 2009 0.77
103 Joint Effect of Childhood Abuse and Family History of Major Depressive Disorder on Rates of PTSD in People with Personality Disorders. Depress Res Treat 2012 0.77
104 The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder. J Clin Psychopharmacol 2009 0.76
105 Blunted hormone responses to Ipsapirone are associated with trait impulsivity in personality disorder patients. Neuropsychopharmacology 2006 0.76
106 Vocational functioning in schizotypal and paranoid personality disorders. Psychiatry Res 2013 0.76
107 Schizotypal personality disorder. J Pers Disord 2012 0.76
108 Evidence-based pharmacotherapy for personality disorders. Int J Neuropsychopharmacol 2011 0.76
109 "Late-onset" borderline personality disorder: a life unraveling. Harv Rev Psychiatry 2002 0.76
110 Paranoid personality disorder. J Pers Disord 2012 0.75
111 No link of serotonin 2C receptor editing to serotonin transporter genotype. Neuroreport 2010 0.75
112 It is time to take a stand for medical research and against terrorism targeting medical scientists. Biol Psychiatry 2008 0.75
113 Erratum: The relationship between dopamine receptor D1 and cognitive performance. NPJ Schizophr 2015 0.75
114 Personality disorders. Handb Clin Neurol 2012 0.75
115 Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes. Psychiatry Res 2004 0.75